Mechanistically, tumor-derived transforming growth factor-beta (TGF-β) plays a central role in dampening NKT cell effector functions by downregulating activating receptors and impairing cytokine production, particularly IFNγ [85]. The gene discussed is IFNG; the disease is neoplasm.